Journal Article Summary
The article investigates the role of desloratadine, an antihistamine typically used for allergies, in treating hepatocellular carcinoma (HCC), a common and aggressive form of liver cancer. The study is significant because HCC has a poor prognosis and current treatments often fail due to drug resistance. Researchers aimed to identify new therapeutic options by screening a library of FDA-approved drugs, focusing on understanding the mechanisms behind HCC progression and potential new treatments.
In their research, the authors conducted various experiments using HCC cell lines and animal models to assess the effects of desloratadine on cancer cell growth and survival. They discovered that desloratadine inhibits the proliferation of HCC cells and reduces tumor growth in xenograft models. The study identified N-myristoyl transferase 1 (NMT1) as a target of desloratadine, which plays a crucial role in modifying proteins that promote cancer progression. By inhibiting NMT1, desloratadine disrupts the myristoylation of the VILIP3 protein, which is linked to poor patient outcomes in HCC.
Despite these promising findings, the study has limitations, including its preclinical nature, meaning results may not directly translate to human patients. Additionally, the long-term safety and efficacy of desloratadine for cancer treatment are not yet established. Patients and caregivers should consult healthcare professionals about the implications of these findings, especially regarding potential new treatment options and the importance of ongoing monitoring and management of HCC.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Tan Xiang-Peng, He Yan, Yang Jing, Wei Xian, Fan You-Long, Zhang Guo-Geng, Zhu Yi-Dong, Li Zheng-Qiu, et al.. Blockade of NMT1 enzymatic activity inhibits N-myristoylation of VILIP3 protein and suppresses liver cancer progression. Signal Transduction and Targeted Therapy 2023. DOI: 10.1038/s41392-022-01248-9. PMID: 36617552. PMCID: PMC9826789.
Featured Pill Pals Product
Loratadine 10 mg --- 300 Count Bottle --- Generic For Claritin --- Major / Rugby --- Over The Counter
Loratadine 10 mg — 300 Count Bottle — Generic For Claritin — Major / Rugby — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
